A detailed history of Avion Wealth transactions in Incyte Corp stock. As of the latest transaction made, Avion Wealth holds 54 shares of INCY stock, worth $3,872. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54
Previous 46 17.39%
Holding current value
$3,872
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$57.33 - $68.61 $458 - $548
8 Added 17.39%
54 $3,000
Q2 2024

Jul 26, 2024

BUY
$51.18 - $63.75 $1,842 - $2,295
36 Added 360.0%
46 $2,000
Q4 2023

Jan 26, 2024

SELL
$52.16 - $64.19 $730 - $898
-14 Reduced 58.33%
10 $1,000
Q3 2023

Oct 20, 2023

SELL
$57.77 - $65.93 $462 - $527
-8 Reduced 25.0%
24 $1,000
Q2 2023

Jul 14, 2023

BUY
$60.95 - $75.51 $1,401 - $1,736
23 Added 255.56%
32 $1,000
Q1 2023

May 05, 2023

BUY
$70.23 - $86.01 $632 - $774
9 New
9 $0

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Avion Wealth Portfolio

Follow Avion Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avion Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Avion Wealth with notifications on news.